As shown in Fig. 1c and d, sFRP2 is significantly upregulated in the primary bone tumor from patients with metastatic disease compared to tumors from patients with only localized disease, and within the highly metastatic human osteosarcoma cell line 143B compared to its paired cell line HOS that has low metastatic potential. Here, SFRP2 is linked to osteosarcoma.